These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24849770)

  • 1. Optimal tuberculosis prevention and control strategy from a mathematical model based on real data.
    Choi S; Jung E
    Bull Math Biol; 2014 Jul; 76(7):1566-89. PubMed ID: 24849770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal intervention strategy for prevention tuberculosis using a smoking-tuberculosis model.
    Choi S; Jung E; Lee SM
    J Theor Biol; 2015 Sep; 380():256-70. PubMed ID: 26025317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dynamic model for tuberculosis transmission and optimal treatment strategies in South Korea.
    Whang S; Choi S; Jung E
    J Theor Biol; 2011 Jun; 279(1):120-31. PubMed ID: 21439972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical model and intervention strategies for mitigating tuberculosis in the Philippines.
    Kim S; de Los Reyes AA; Jung E
    J Theor Biol; 2018 Apr; 443():100-112. PubMed ID: 29407656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of and risk factors for active tuberculosis in human immunodeficiency virus-infected patients in South Korea.
    Ku NS; Choi YH; Kim YK; Choi JP; Kim JM; Choi JY
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):777-81. PubMed ID: 23676161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model for cellular immunology of tuberculosis.
    Ibarguen-Mondragon E; Esteva L; Chávez-Galán L
    Math Biosci Eng; 2011 Oct; 8(4):973-86. PubMed ID: 21936595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal control of a two-strain tuberculosis-HIV/AIDS co-infection model.
    Agusto FB; Adekunle AI
    Biosystems; 2014 May; 119():20-44. PubMed ID: 24704209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis control in the Republic of Korea.
    Cho KS
    Epidemiol Health; 2018; 40():e2018036. PubMed ID: 30081621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievements in and Challenges of Tuberculosis Control in South Korea.
    Kim JH; Yim JJ
    Emerg Infect Dis; 2015 Nov; 21(11):1913-20. PubMed ID: 26485188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
    Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational exposure to tuberculosis--OSHA. Proposed rule and notice of public hearing.
    Fed Regist; 1997 Oct; 62(201):54160-308. PubMed ID: 10177300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
    Dowdy DW; Chaisson RE; Moulton LH; Dorman SE
    AIDS; 2006 Mar; 20(5):751-62. PubMed ID: 16514306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
    Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling local and global effects on the risk of contracting Tuberculosis using stochastic Markov-chain models.
    Hoad KA; van't Hoog AH; Rosen D; Marston B; Nyabiage L; Williams BG; Dye C; Cheng RC
    Math Biosci; 2009 Apr; 218(2):98-104. PubMed ID: 19563744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model for evaluating tuberculosis screening strategies.
    Jia Z; Cheng S; Jia X
    J Evid Based Med; 2011 Feb; 4(1):48-52. PubMed ID: 21342483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for advancing tuberculosis control efforts through novel therapies.
    Salomon JA; Lloyd-Smith JO; Getz WM; Resch S; Sánchez MS; Porco TC; Borgdorff MW
    PLoS Med; 2006 Aug; 3(8):e273. PubMed ID: 16866578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.